Abstract
Purpose: To evaluate androgen production and metabolism during controlled ovarian hyperstimulation.
Methods: Five women, aged 33–42, were studied. All participants were undergoing controlled ovarian hyperstimulation with gonadotropin-releasing hormone agonist and human menopausal gonadotropins. Serum estradiol, estrone, androstenedione, testosterone, 3α-androstanediol glucuronide, and sex hormone-binding globulin levels were measured at 6 time points during the cycle.
Results: The levels of all steroids increased significantly from baseline during controlled ovarian hyperstimulation. Mean total testosterone levels increased from 0.29 ± 0.05 ng/mL to 0.58 ± 0.07 ng/mL after gonadotropin stimulation. Sex hormone-binding gonadotropin levels increased from 50 ± 16 nM to 73 ± 12 nM after gonadotropin stimulation. Estrone/androstenedione and estradiol/testosterone ratios, reflecting the aromatase pathway, increased whereas 3α-androstanediol glucuronide/androstenedione and 3α-androstanediol glucuronide/testosterone ratios, reflecting 5α-reductase activity, decreased.
Conclusions: Controlled ovarian hyperstimulation with human menopausal gonadotropins results in increased serum testosterone and androstenedione levels. Whereas there is an enhancement in androgen metabolism by aromatase, 5α-reductase activity with regard to androgen metabolism is diminished.
Similar content being viewed by others
REFERENCES
Martin KA, Hornstein MD, Taylor AE, Hall JE, Barbieri RL: Exogenous gonadotropin stimulation is associated with increases in serum androgen levels in in-vitro fertilization-embryo transfer cycles. Fertil Steril 1997;68:1011-1016
Adashi EY:The climacteric ovary as a functional gonadotropindriven androgen-producing gland. Fertil Steril 1994;62: 20-27
Gelety TJ, Surrey ES: Incomplete androgen and progesterone suppression following midluteal GnRHa prior to controlled ovarian hyperstimulation for IVF-ET. J Assist Reprod Genet 1997;14:525-530
Fanchin R, Righini C, Olivennes F, Taieb J, de Ziegler D, Frydman R: Premature plasma progesterone and androgen elevation are not prevented by adrenal suppression in in vitro fertilization. Fertil Steril 1997;67:115-119
Yong EL, Hillier SG, Turner M, Baird DT, Ng SC, Bongso A, Ratnam SS: Differential regulation of cholesterol side-chain cleavage (P450scc) and aromatase (P450arom) enzymemRNA expression by gonadotrophins and cyclic AMP in human granulosa cells. J Mol Endocrinol 1994;12:239-249
Polan ML, Daniele A, Russell JB, DeCherney AH: Ovulation induction with human menopausal gonadotropin compared to human urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa-luteal cell function. J Clin Endocrinol Metab 1986;63:1284-1291
Steinkampf MP, Mendelson CR, Simpson ER: Regulation by follicle-stimulating hormone of the synthesis of aromatase cytochrome P-450 in human granulosa cells. Mol Endocrinol 1987;1:465-471
Yong EL, Baird DT, Yates R, Reichert LE Jr, Hillier SG: Hormonal regulation of the growth and steroidogenic function of human granulosa cells. J Clin Endocrinol Metab 1992;74:842-849
Paulson RJ, Serafini PC, Catalino JA, Lobo RA: Measurements of 3?,17ß-androstanediol glucuronide in serum and urine and the correlation with skin 5?-reductase activity. Fertil Steril 1986;46:222-226
Goebelsmann U, Horton R, Mestman JH, Arce JJ, Nagata Y, Nakamura RM, Thorneycroft IH, Mishell DR Jr: Male pseudohermaphroditism due to testicular 17ß-hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 1973;36:867-879
Goebelsmann U, Arce JJ, Thorneycorft IH, Mishell DR Jr: Serum testosterone concentrations in women throughout the menstrual cycle and following hCG administration. Am J Obstet Gynecol 1974;119:445-452
Wong IL, Morris RS, Chang L, Spahn M-A, Stanczyk FZ, Lobo RA: A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women. J Clin Endocrinol Metab 1995;80:233-238
Goebelsmann U, Bernstein GS, Gale JA, Kletzky OA, Nakamura RM, Coulson AM, Korelitz JJ: Serum gonadotropin, testosterone, estradiol and estrone levels prior to and following bilateral vasectomy. InVasectomy: Immunologic and Pathophysiologic Effects in Animals and Man, JH Lepow, R Crozier (eds.), NewYork, Academic Press, 1979, pp. 165-175
Stanczyk FZ: Steroid hormones. In Mishell's Textbook of Infertility, Contraception, and Reproductive Endocrinology, 4th edn., RA Lobo, DR Mishell Jr, RJ Paulson, D Shoupe (eds.), Malden, Blackwell Science, 1997, pp. 46-66
Liu CH, Laughlin GA, Fischer UG, Yen SS: Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: Evidence for a reduced 17,20-desmolase enzymatic activity. J Clin Endocrinol Metab 1990;71:900-906
Medina M, Herrera J, Flores M, Martin O, Bermudez JA, Zarate A: Normal ovarian function in a mild form of late-onset 3ß-hydroxysteroid dehydrogenase deficiency. Fertil Steril 1986;46:1021-1025
Chang YT, Zhang L, Alkaddour HS, Mason JI, Lin K, Yang X, et al.: Absence of molecular defect in the type II 3ß-hydroxysteroid dehydrogenase (3ß-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3ß-HSD activity. Pediatr Res 1995;37:820-824
Speroff L, Glass RH, Kase NG, eds.: Hormone biosynthesis, metabolism, and mechanism of action. In Clinical Gynecologic Endocrinology and Infertility, 6th edn., Philadelphia, Lippincott Williams &Wilkins, 1999, pp. 31-105
Holt JA: Reproductive hormones and their mechanisms of action. In Mishell's Textbook of Infertility, Contraception, and Reproductive Endocrinology, 4th edn., RA Lobo, DR Mishell Jr, RJ Paulson, D Shoupe (eds.), Malden, Blackwell Science, 1997, pp. 26-45
Toscano V, Balducci R, Bianchi P, Guglielmi R, Mangiantini A, Sciarra F: Steroidal and non-steroidal factors in plasma sex hormone binding globulin regulation. J Steroid Biochem Mol Biol 1992;43:431-437
Cassidenti DL, Paulson RJ, Serafini P, Stanczyk FZ, Lobo RA: Effects of sex steroids on skin 5?-reductase activity in vitro. Obstet Gynecol 1991;78:103-107
Krieg M, Schlenker A, Voigt K: Inhibition of androgen metabolism in stroma and epithelium of the human benign prostatic hyperplasia by progesterone, estrone, and estradiol. Prostate 1985;6:233-240
Serafini PC, Catalino J, Lobo RA: The effect of spironolactone on genital skin 5?-reductase activity. J Steroid Biochem 1985;23:191-194
Serafini P, Lobo RA: Prolactin modulates peripheral androgen metabolism. Fertil Steril 1986;45:41-46
Kuttenn F, Rigaud C, Wright F, Mauvais-Jarvis P: Treatment of hirsutism by oral cyproterone acetate and percutaneous estradiol. J Clin Endocrinol Metab 1980;51:1107-1111
Dean HJ, Winter JS: The effect of five synthetic progestational compounds on 5?-reductase activity in genital skin fibroblast monolayers. Steroids 1984;43:13-24
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Slater, C.C., Chang, L., Stanczyk, F.Z. et al. Clinical Assisted Reproduction: Altered Balance Between the 5α-Reductase and Aromatase Pathways of Androgen Metabolism During Controlled Ovarian Hyperstimulation with Human Menopausal Gonadotropins. J Assist Reprod Genet 18, 527–533 (2001). https://doi.org/10.1023/A:1011914218410
Issue Date:
DOI: https://doi.org/10.1023/A:1011914218410